Log In Get Started

Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

24,446 total articles

Jade Biosciences to Host Conference Call and Webcast on June 1, 2026, at 8:00 a.m. ET to Discuss Interim Phase 1 Healthy Volunteer Results for JADE101, a Novel, Potentially Best-in-Class Anti-APRIL Monoclonal Antibody in Development for IgA Nephropathy
May 29, 2026
Leila Farooq
Press Releases

Jade Biosciences to Host Conference Call and Webcast on June 1, 2026, at 8:00 a.m. ET to Discuss Interim Phase 1 Healthy Volunteer Results for JADE101, a Novel, Potentially Best-in-Class Anti-APRIL Monoclonal Antibody in Development for IgA Nephropathy

Jade Biosciences announced a conference call to discuss interim Phase 1 healthy volunteer results for JADE101, their novel anti-APRIL monoclonal antibody targeting immunoglobulin A nephropathy (IgAN). The data is expected to inform dosing strategy and characterize the clinical profile of this potentially best-in-class therapy. JADE101 shows promisi…

JBIO
Arvinas to Present at Jefferies Global Healthcare Conference
May 29, 2026
Priya Menon
Press Releases

Arvinas to Present at Jefferies Global Healthcare Conference

Arvinas, Inc., a clinical-stage biotech company specializing in targeted protein degradation therapies, announced its management will present at the Jefferies Global Healthcare Conference. The presentation will cover its PROTAC platform, FDA-approved drug VEPPANU™, and several investigational drugs targeting neurodegenerative diseases, cancers, and…

ARVN
Kiniksa Pharmaceuticals to Present at Upcoming Investor Conferences
May 29, 2026
Sofia Navarro
Press Releases

Kiniksa Pharmaceuticals to Present at Upcoming Investor Conferences

Kiniksa Pharmaceuticals International, plc announced management's participation in fireside chats at the Jefferies Global Healthcare Conference and Goldman Sachs Annual Global Healthcare Conference in June 2026. Presentations will be webcast live and available for replay on the company's website, highlighting the company's commitment to engaging wi…

KNSA
Allied Gold Advances Receipt of Regulatory Approvals and Clearances in Connection with the Proposed Arrangement with Zijin Gold International and Extends the Outside Date to July 29, 2026
May 29, 2026
Avery Klein
Press Releases

Allied Gold Advances Receipt of Regulatory Approvals and Clearances in Connection with the Proposed Arrangement with Zijin Gold International and Extends the Outside Date to July 29, 2026

Allied Gold Corporation announced significant progress in obtaining regulatory approvals from Canadian, West African, and other African authorities related to Zijin Gold's proposed acquisition of Allied Gold. The Investment Canada Act approval has been secured, marking a major milestone toward completing the transaction. The companies have extended…

AAUC
Cuprina Holdings Announces Completion of Reverse Stock Split and Requests a Hearing before the Nasdaq Hearings Panel to Maintain Listing
May 29, 2026
Maya Rios
Press Releases

Cuprina Holdings Announces Completion of Reverse Stock Split and Requests a Hearing before the Nasdaq Hearings Panel to Maintain Listing

Cuprina Holdings completed a reverse stock split to increase its share price and requested a hearing before the Nasdaq Hearings Panel to appeal a delisting decision after failing to meet Nasdaq's minimum bid price requirement. The company aims to maintain its listing on The Nasdaq Capital Market amid ongoing compliance challenges.

CUPR
MannKind Announces FDA Approval of Afrezza®, the First and Only Inhaled Mealtime Insulin for Use in Children and Adolescents Aged 6 and Older Living with Diabetes
May 29, 2026
Marcus Reed
Press Releases

MannKind Announces FDA Approval of Afrezza®, the First and Only Inhaled Mealtime Insulin for Use in Children and Adolescents Aged 6 and Older Living with Diabetes

MannKind Corporation announced FDA approval for Afrezza, the first inhaled mealtime insulin for children aged 6 and older with type 1 and type 2 diabetes. This approval provides a novel, needle-free insulin option that offers rapid onset and dosing flexibility, potentially improving glycemic control and quality of life for pediatric patients and th…

MNKD
ATN International, Inc. to Present and Host 1x1 Investor Meetings at the 16th Annual East Coast IDEAS Investor Conference on June 11, 2026 in New York
May 29, 2026
Derek Hwang
Press Releases

ATN International, Inc. to Present and Host 1x1 Investor Meetings at the 16th Annual East Coast IDEAS Investor Conference on June 11, 2026 in New York

ATN International, a leading digital infrastructure and communications services provider, announced its participation in the 16th Annual East Coast IDEAS Investor Conference on June 11, 2026. The company will host one-on-one investor meetings and a live webcast presentation, highlighting its focus on rural and remote markets in the U.S. and Caribbe…

ATNI
Roofing Reality Check: Risk Is Rising Even in Quiet Storm Years
May 29, 2026
Derek Hwang
Press Releases

Roofing Reality Check: Risk Is Rising Even in Quiet Storm Years

Verisk Analytics released its 2026 U.S. Roof Report showing that in 2025, average residential roof replacement costs rose 33% and repair costs climbed 25% compared to the prior four-year average, despite a nearly 20% decline in overall claims volume. The report cites frequent smaller hail events, aging roofs, and regional volatility as key drivers …

VRSK
Genius Group Provides Response to Unusual Market Activity
May 29, 2026
Leila Farooq
Press Releases

Genius Group Provides Response to Unusual Market Activity

Genius Group Limited (NYSE American: GNS) issued a statement responding to an unusual spike in its share price and trading volume on May 27-28, 2026, confirming there are no undisclosed material developments to explain the activity. The company highlighted recent significant corporate initiatives including approval of an AI Treasury strategy target…

GNS
Talkspace Stockholders Vote to Approve Acquisition by UHS
May 29, 2026
Avery Klein
Press Releases

Talkspace Stockholders Vote to Approve Acquisition by UHS

Talkspace, Inc., a leading virtual behavioral healthcare provider, announced that its stockholders have approved the acquisition by Universal Health Services (UHS). The merger is expected to complete in the third quarter of 2026 pending regulatory approvals and other customary closing conditions. The acquisition aims to expand access to high-qualit…

TALK
The Next Great AI Revolution May Be Drug Delivery
May 29, 2026
Leila Farooq
Press Releases

The Next Great AI Revolution May Be Drug Delivery

NeOnc Technologies Holdings (NASDAQ:NTHI) is gaining investor attention as it develops AI-enhanced delivery technologies aimed at overcoming challenges like the blood-brain barrier in treating aggressive brain cancers such as glioblastoma. Leveraging AI and precision medicine, NeOnc is positioned at the forefront of a shifting biotech paradigm focu…

NTHI
Duluth Trading Co. Expands Online and In-Store “Garden Shop” with Protective Apparel and Durable Gear
May 29, 2026
Avery Klein
Press Releases

Duluth Trading Co. Expands Online and In-Store “Garden Shop” with Protective Apparel and Durable Gear

Duluth Trading Co. has expanded and refreshed its Garden Shop both online and in over 60 retail stores, focusing on durable and functional gardening apparel and accessories for women and men. The refreshed collection includes best-selling Heirloom Gardening Bib Overalls for women with high customer ratings, new gardening pants, and an expanded men'…

DLTH
BioNexus Gene Lab Corp. Calls for Malaysia–China Biotechnology Cooperation to Move Beyond Trade into Co-Development
May 29, 2026
Avery Klein
Press Releases

BioNexus Gene Lab Corp. Calls for Malaysia–China Biotechnology Cooperation to Move Beyond Trade into Co-Development

BioNexus Gene Lab Corp. emphasized at the 2026 China–Malaysia Economic Cooperation Outlook Forum the shift in Malaysia-China biotech collaboration from mere trade to strategic co-development, clinical validation, and commercialization across ASEAN. The company highlights its role as an ASEAN hub for precision diagnostics, AI-driven healthcare data,…

BGLC